Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 271 AL 285

Vascular Considerations for Amyloid Immunotherapy

Foley KE, Wilcock DM.

Curr Neurol Neurosci Rep. 2022 Nov;22(11):709-719. doi: 10.1007/s11910-022-01235-1. Epub 2022 Oct 21.

Meta analysis of aerobic exercise improving intelligence and cognitive function in patients with Alzheimer's disease

Zhou XP, Zhang LM, Chen GQ, Wang SW, He JF, Li Z, Zhang BS.

Medicine (Baltimore). 2022 Oct 21;101(42):e31177. doi: 10.1097/MD.0000000000031177.

Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid

Yaari R, Holdridge KC, Choi J, Donohue MC, Kantarci K, Jack CR Jr, Zuk SM, Sims JR, Johnson KA, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2022;9(4):617-624. doi: 10.14283/jpad.2022.56.

Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults

Silverman MH, Duggan S, Bardelli G, Sadler B, Key C, Medlock M, Reynolds L, Wallner B.

J Prev Alzheimers Dis. 2022;9(4):635-645. doi: 10.14283/jpad.2022.71.

Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate

Wischik CM, Bentham P, Gauthier S, Miller S, Kook K, Schelter BO.

J Prev Alzheimers Dis. 2022;9(4):780-790. doi: 10.14283/jpad.2022.63.

Myelin repair in Alzheimer's disease: a review of biological pathways and potential therapeutics

Hirschfeld LR, Risacher SL, Nho K, Saykin AJ.

Transl Neurodegener. 2022 Oct 26;11(1):47. doi: 10.1186/s40035-022-00321-1.

Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound

Baazaoui N, Iqbal K.

Biomolecules. 2022 Oct 2;12(10):1409. doi: 10.3390/biom12101409.

Polypharmacy in Older Adults with Alzheimer's Disease

Esumi S, Ushio S, Zamami Y.

Medicina (Kaunas). 2022 Oct 13;58(10):1445. doi: 10.3390/medicina58101445.

Targeting Alzheimer's Disease: The Critical Crosstalk between the Liver and Brain

Huang Z, Lin HWK, Zhang Q, Zong X.

Nutrients. 2022 Oct 14;14(20):4298. doi: 10.3390/nu14204298.

Aducanumab for the treatment of Alzheimer's disease

Tagliapietra M.

Drugs Today (Barc). 2022 Oct;58(10):465-477. doi: 10.1358/dot.2022.58.10.3422314.

Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease

Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, Delgado-Lara DLC, García Martínez MT, Mireles-Ramírez MA, Cruz Serrano JA, Pacheco Moisés FP.

Nutr Hosp. 2022 Dec 20;39(6):1364-1368. doi: 10.20960/nh.04153.

Potential of astrocytes in targeting therapy for Alzheimer's disease

Bi W, Lei T, Cai S, Zhang X, Yang Y, Xiao Z, Wang L, Du H.

Int Immunopharmacol. 2022 Dec;113(Pt A):109368. doi: 10.1016/j.intimp.2022.109368. Epub 2022 Oct 29.

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect

Ferreira I, Rauter AP, Bandarra NM.

Mar Drugs. 2022 Oct 25;20(11):662. doi: 10.3390/md20110662.

Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics

Avgerinos KI, Mullins RJ, Vreones M, Mustapic M, Chen Q, Melvin D, Kapogiannis D, Egan JM.

Cells. 2022 Oct 25;11(21):3372. doi: 10.3390/cells11213372.

Exploring New Vista for Alzheimer's Disease Drug Targets

Kumar D.

Curr Top Med Chem. 2022;22(22):1847-1848. doi: 10.2174/156802662222221007161622.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias